An article on ISTA Pharmaceuticals Inc. in the July 29, 2003, issue of BioWorld Today incorrectly said ISTA had dropped the manufacturer first selected to make Istalol. Instead, it is qualifying an alternative manufacturer. Also, the story should have said ISTA hopes to file for regulatory approval for bromfenac in early 2004 (not late 2003), and that it is conducting a feasibility study on Caprogel and will decide later whether to conduct a Phase III study.

Editor's note: The changes have been made on BioWorld Online.